Targeting Transforming Growth Factor β to Enhance Cancer Immunotherapy
Department of Microbiology and Immunology, University of Arizona, 1501 N. Campbell Avenue, P.O. Box 245049, Tucson, AZ 85724, USA
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2006, 13(4), 141-143; https://doi.org/10.3390/curroncol13040015
Submission received: 12 May 2006
/
Revised: 3 June 2006
/
Accepted: 4 July 2006
/
Published: 1 August 2006
Excerpt
Note: In lieu of an abstract, this is an excerpt from the first page.
Human tumours have evolved intricate mechanisms to evade the immune system, either by avoiding recognition or by inhibiting and eliminating immune cells. [...]
Keywords:
DC-based vaccine; TGFβ; immunotherapy of cancer
Share and Cite
MDPI and ACS Style
Hahn, T.; Akporiaye, E.T. Targeting Transforming Growth Factor β to Enhance Cancer Immunotherapy. Curr. Oncol. 2006, 13, 141-143. https://doi.org/10.3390/curroncol13040015
AMA Style
Hahn T, Akporiaye ET. Targeting Transforming Growth Factor β to Enhance Cancer Immunotherapy. Current Oncology. 2006; 13(4):141-143. https://doi.org/10.3390/curroncol13040015
Chicago/Turabian StyleHahn, T., and Emmanuel T. Akporiaye. 2006. "Targeting Transforming Growth Factor β to Enhance Cancer Immunotherapy" Current Oncology 13, no. 4: 141-143. https://doi.org/10.3390/curroncol13040015
